相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pathogenesis of Mucopolysaccharidoses, an Update
Simona Fecarotta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experience
Annalisa Sechi et al.
MOLECULAR GENETICS AND METABOLISM (2020)
A comprehensive review of COVID-19 characteristics
Hanie Esakandari et al.
BIOLOGICAL PROCEDURES ONLINE (2020)
Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19-COVID-NET, 14 States, March 1-July 25, 2020
Lindsay Kim et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Enzyme replacement therapy interruption in patients with Mucopolysaccharidoses: Recommendations for distinct scenarios in Latin America
Martha L. Solano et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2020)
Fabry disease during the COVID-19 pandemic. Why and how treatment should be continued
Juan Politei
MOLECULAR GENETICS AND METABOLISM (2020)
Transcriptomic analyses suggest that mucopolysaccharidosis patients may be less susceptible to COVID-19
Karolina Pierzynowska et al.
FEBS LETTERS (2020)
COVID-19 Pandemic Outbreak and its Psychological Impact on Patients with Rare Lysosomal Diseases
Agata Fiumara et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and Lipidomics
Israa T. Ismail et al.
METABOLITES (2019)
Pompe Disease: From Basic Science to Therapy
Lara Kohler et al.
NEUROTHERAPEUTICS (2018)
Enzyme replacement therapy: efficacy and limitations
Daniela Concolino et al.
ITALIAN JOURNAL OF PEDIATRICS (2018)
Non-neuronopathic lysosomal storage disorders: Disease spectrum and treatments
Gregory M. Pastores et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis
Michael Beck et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2015)
Inborn errors of metabolism underlying primary immunodeficiencies
Nima Parvaneh et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
Rapid deterioration of a patient with mucopolysaccharidosis type I during interruption of enzyme replacement therapy
Grzegorz Wegrzyn et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2007)
Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease
Guillermo Drelichman et al.
JOURNAL OF PEDIATRICS (2007)
Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry disease
Gregory Bierer et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Effect of discontinuing of laronidase in a patient with mucopolysaccharidosis type I
AT Anbu et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
分享论文
